A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer

NCT02959385 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Stage II Esophageal Cancer
Stage III Esophageal Cancer

Interventions

RADIATION: Definitive Radiochemotherapy
PROCEDURE: Neoadjuvant Radiochemotherapy

Sponsor

Tianjin Medical University Cancer Institute and Hospital